Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients

BACKGROUND: Immunocompromised patients are at increased risk of severe COVID-19 and impaired vaccine response. In this observational prospective study, we evaluated immunogenicity of the BNT162b2 mRNA vaccine in cohorts of primary or secondary immunocompromised patients. METHODS: Five clinical group...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyaert, Matthijs, De Scheerder, Marie-Angélique, Van Herrewege, Sophie, Laureys, Guy, Van Assche, Sofie, Cambron, Melissa, Naesens, Leslie, Hoste, Levi, Claes, Karlien, Haerynck, Filomeen, Kerre, Tessa, Van Laecke, Steven, Van Biesen, Wim, Jacques, Peggy, Verhasselt, Bruno, Padalko, Elizaveta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988283/
https://www.ncbi.nlm.nih.gov/pubmed/35401575
http://dx.doi.org/10.3389/fimmu.2022.858399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988283/
https://www.ncbi.nlm.nih.gov/pubmed/35401575
http://dx.doi.org/10.3389/fimmu.2022.858399

Ejemplares similares